Osteoporoza Algoritmik Yaklaşım

Kirazlı Y, Atamaz Çalış F, El Ö, et al. Updated approach for the management of osteoporosis in Turkey: a consensus report. Arch Osteoporos. 2020;15(1):137.

Borman P, Yavuz D, Bahat-Öztürk G, Güzel R, Çatıkkaş NM, editors. Tanıdan tedaviye osteoporoz. Ankara: Bilmedya Yayınevi; 2023.

Türkiye Endokrinoloji ve Metabolizma Derneği. Osteoporoz ve metabolik kemik hastalıkları tanı ve tedavi kılavuzu. Ankara: Bayt Bilimsel Araştırmalar Basın Yayın ve Tanıtım Ltd. Şti.; 2022.

OSHK Task Group for the Formulation of the 2024 OSHK Guideline for Clinical Management of Postmenopausal Osteoporosis in Hong Kong; Ip TP, Lee CA, et al. 2024 OSHK Guideline for clinical management of postmenopausal osteoporosis in Hong Kong. Hong Kong Med J. 2024;30(Suppl 2):1-44.

Camacho PM, Petak SM, Binkley N, et al. American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis—2020 update. Endocr Pract. 2020;26(Suppl 1):1-46.

Humphrey MB, Russell L, Danila MI, et al. 2022 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol. 2023;75(12):2088-2102.

Buckley L, Guyatt G, Fink HA, et al. 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol. 2017;69(8):1521-1537.

Patel N, Seoudi N. Management of medication-related osteonecrosis of the jaw: an overview of national and international guidelines. Br J Oral Maxillofac Surg. 2024;62(10):899-908.

AlRowis R, Aldawood A, AlOtaibi M, et al. Medication-related osteonecrosis of the jaw (MRONJ): a review of pathophysiology, risk factors, preventive measures and treatment strategies. Saudi Dent J. 2022;34(3):202-210.

Nicolatou-Galitis O, Schiødt M, Mendes RA, et al. Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;127(2):117-135.

Otto S, Aljohani S, Fliefel R, et al. Infection as an important factor in medication-related osteonecrosis of the jaw (MRONJ). Medicina (Kaunas). 2021;57:463.

Kawahara M, Kuroshima S, Sawase T. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review. Int J Implant Dent. 2021;7:47.

Matus-Miranda G, Mancilla A, Martínez R, et al. Utility of biomarkers in predicting the development of medication-related osteonecrosis of the jaws: a scoping review. J Oral Maxillofac Surg Med Pathol. 2024;36(4):383-387.

Peichl P, Holzer LA, Maier R, Holzer G. Parathyroid hormone 1-84 accelerates fracture healing in pubic bones of elderly osteoporotic women. J Bone Joint Surg Am. 2011;93:1583-1587.

Schürch MA, Rizzoli R, Slosman D, et al. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. Ann Intern Med. 1998;128:801-809.

Gorter EA, Hamdy NA, Appelman-Dijkstra NM, Schipper IB. The role of vitamin D in human fracture healing: a systematic review. Bone. 2014;64:288-297.

Falaschi P, Marsh D. Orthogeriatrics: the management of older patients with fragility fractures. 2nd ed. Cham: Springer; 2021.

Ranhoff AH, Saltvedt I, Frihagen F, et al. Interdisciplinary care of hip fractures: orthogeriatric models and interdisciplinary teamwork. Best Pract Res Clin Rheumatol. 2019;33(2):205-226.

Shin YH, Shin WC, Kim JW. Effect of osteoporosis medication on fracture healing: an evidence-based review. J Bone Metab. 2020;27(1):15-26.

Kirazlı Y, Atamaz Çalış F, El Ö, et al. Updated approach for the management of osteoporosis in Turkey: a consensus report. Arch Osteoporos. 2020;15(1):137.

Borman P, Yavuz D, Bahat-Öztürk G, Güzel R, Çatıkkaş NM, editors. Tanıdan tedaviye osteoporoz. Ankara: Bilmedya Yayınevi; 2023.

Türkiye Endokrinoloji ve Metabolizma Derneği. Osteoporoz ve metabolik kemik hastalıkları tanı ve tedavi kılavuzu. Ankara: Bayt Bilimsel Araştırmalar Basın Yayın ve Tanıtım Ltd. Şti.; 2022.

OSHK Task Group for the Formulation of the 2024 OSHK Guideline for Clinical Management of Postmenopausal Osteoporosis in Hong Kong; Ip TP, Lee CA, et al. 2024 OSHK Guideline for clinical management of postmenopausal osteoporosis in Hong Kong. Hong Kong Med J. 2024;30(Suppl 2):1-44.

Camacho PM, Petak SM, Binkley N, et al. American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis—2020 update. Endocr Pract. 2020;26(Suppl 1):1-46.

Humphrey MB, Russell L, Danila MI, et al. 2022 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol. 2023;75(12):2088-2102.

Buckley L, Guyatt G, Fink HA, et al. 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol. 2017;69(8):1521-1537.

Patel N, Seoudi N. Management of medication-related osteonecrosis of the jaw: an overview of national and international guidelines. Br J Oral Maxillofac Surg. 2024;62(10):899-908.

AlRowis R, Aldawood A, AlOtaibi M, et al. Medication-related osteonecrosis of the jaw (MRONJ): a review of pathophysiology, risk factors, preventive measures and treatment strategies. Saudi Dent J. 2022;34(3):202-210.

Nicolatou-Galitis O, Schiødt M, Mendes RA, et al. Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;127(2):117-135.

Otto S, Aljohani S, Fliefel R, et al. Infection as an important factor in medication-related osteonecrosis of the jaw (MRONJ). Medicina (Kaunas). 2021;57:463.

Kawahara M, Kuroshima S, Sawase T. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review. Int J Implant Dent. 2021;7:47.

Matus-Miranda G, Mancilla A, Martínez R, et al. Utility of biomarkers in predicting the development of medication-related osteonecrosis of the jaws: a scoping review. J Oral Maxillofac Surg Med Pathol. 2024;36(4):383-387.

Peichl P, Holzer LA, Maier R, Holzer G. Parathyroid hormone 1-84 accelerates fracture healing in pubic bones of elderly osteoporotic women. J Bone Joint Surg Am. 2011;93:1583-1587.

Schürch MA, Rizzoli R, Slosman D, et al. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. Ann Intern Med. 1998;128:801-809.

Gorter EA, Hamdy NA, Appelman-Dijkstra NM, Schipper IB. The role of vitamin D in human fracture healing: a systematic review. Bone. 2014;64:288-297.

Falaschi P, Marsh D. Orthogeriatrics: the management of older patients with fragility fractures. 2nd ed. Cham: Springer; 2021.

Ranhoff AH, Saltvedt I, Frihagen F, et al. Interdisciplinary care of hip fractures: orthogeriatric models and interdisciplinary teamwork. Best Pract Res Clin Rheumatol. 2019;33(2):205-226.

Shin YH, Shin WC, Kim JW. Effect of osteoporosis medication on fracture healing: an evidence-based review. J Bone Metab. 2020;27(1):15-26.